Polaris Group (TPE:6550)
16.35
-0.35 (-2.10%)
Oct 12, 2026, 1:30 PM CST
Polaris Group Market Cap
Polaris Group has a market cap or net worth of 7.6 billion as of October 12, 2026. It is the 19,755th most valuable company in the world and the 871st biggest in Taiwan. Its market cap has decreased by 72.97% in one year.
Market Cap
7.60B
Enterprise Value
8.62B
Revenue
67.95M
Global Rank
Country Rank
#871 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since February 15, 2016, Polaris Group's market cap has decreased from 46.46B to 7.60B, a decrease of -83.64%. That is a compound annual growth rate of -15.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2026 | 7.60B | -68.28% |
| Dec 31, 2025 | 23.96B | -29.66% |
| Dec 31, 2024 | 34.06B | -39.39% |
| Dec 29, 2023 | 56.21B | -14.57% |
| Dec 30, 2022 | 65.79B | 24.20% |
| Dec 30, 2021 | 52.97B | 373.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Locus Cell | 9.82B |
| TCM Biotech International | 9.80B |
| Tanvex BioPharma | 9.00B |
| PharmaEngine | 8.22B |
| Adimmune | 8.09B |
| AnnJi Pharmaceutical | 7.85B |
| Acepodia | 7.81B |
| Savior Lifetec | 7.29B |